Journal of Stroke & Cerebrovascular Diseases
Volume 17, Issue 3 , Pages 109-115 , May 2008

Living Well with Stroke: Design and Methods for a Randomized Controlled Trial of a Psychosocial Behavioral Intervention for Poststroke Depression

  • Pamela H. Mitchell, PhD

      Affiliations

    • Department of Biobehavioral Nursing and Health Systems, School of Nursing and School of Medicine, University of Washington, Seattle Washington
    • Corresponding Author InformationAddress correspondence to Pamela H. Mitchell, PhD, Box 357266, University of Washington, Seattle, WA 98195-7266.
    • ,
  • Linda Teri, PhD

      Affiliations

    • Department of Psychosocial and Community Health, School of Nursing and School of Medicine, University of Washington, Seattle Washington
    • ,
  • Richard Veith, MD

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, School of Nursing and School of Medicine, University of Washington, Seattle Washington
    • ,
  • Ann Buzaitis, MN

      Affiliations

    • Department of Biobehavioral Nursing and Health Systems, School of Nursing and School of Medicine, University of Washington, Seattle Washington
    • ,
  • David Tirschwell, MD, MSc

      Affiliations

    • Department of Neurology, School of Nursing and School of Medicine, University of Washington, Seattle Washington
    • ,
  • Kyra Becker, MD

      Affiliations

    • Department of Neurology, School of Nursing and School of Medicine, University of Washington, Seattle Washington
    • ,
  • Michael Fruin, MN

      Affiliations

    • Department of Biobehavioral Nursing and Health Systems, School of Nursing and School of Medicine, University of Washington, Seattle Washington
    • ,
  • Ruth Kohen, MD

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, School of Nursing and School of Medicine, University of Washington, Seattle Washington
    • ,
  • Kevin C. Cain, PhD

      Affiliations

    • Department of Biostatistics and Office for Nursing Research, School of Nursing and School of Medicine, University of Washington, Seattle Washington

Received 26 June 2007 ,Revised 13 November 2007 ,Accepted 7 December 2007.

References 

  1. Hackett ML, Yapa C, Parag V, et al. Frequency of depression after stroke: A systematic review of observational studies. Stroke. 2005;36:1330–1340
  2. van de Weg FB, Kuik DJ, Lankhorst GJ. Post-stroke depression and functional outcome: A cohort study investigating the influence of depression on functional recovery from stroke. Clin Rehabil. 1999;13:268–272
  3. Herrman N, Black SE, Lawrence J, et al. The Sunnybrook stroke study: A prospective study of depressive symptoms and functional outcome. Stroke. 1998;29:618–624
  4. Shimoda K, Robinson RG. The relationship between social impairment and recovery from stroke. Psychiatry. 1998;61:101–111
  5. Ramasubbu R, Robinson RG, Flint AJ, et al. Functional impairment associated with acute poststroke depression: The stroke data bank study. J Neuropsychiatry Clin Neurosci. 1998;10:26–33
  6. Morris PLP, Raphael B, Robinson RS. Clinical depression is associated with impaired recovery from sroke. Med J Aust. 1992;157:239–242
  7. Ormel J, Kempen GI, Deeg DJ, et al. Functioning, well-being, and health perception in late middle-aged and older people: Comparing the effects of depressive symptoms and chronic medical conditions. J Am Geriatr Soc. 1998;46:39–48
  8. Clark MS, Smith DS. The effects of depression and abnormal illness behavior on outcome following rehabilitation from stroke. Clin Rehabil. 1998;12:73–80
  9. Neau JP, Ingrand P, Mouille-Brachet C, et al. Functional recovery and social outcome after cerebral infarction in young adults. Cerebrovasc Dis. 1998;8:296–302
  10. Parikh RM, Robinson RG, Lipsey JR, et al. The impact of poststroke depression on recovery in activities of daily living over a 2-year follow-up. Arch Neurol. 1990;47:785–789
  11. Everson SA, Roberts RE, Goldberg DE, et al. Depressive symptoms and increased risk of stroke mortality over a 29-year period. Arch Intern Med. 1998;158:1133–1138
  12. Morris PL, Robinson RG, Andrzejewski P, et al. Association of depression with 10-year poststroke mortality. Am J Psychiatry. 1993;150:124–129
  13. Hackett ML, Anderson CS, House AO. Interventions for treating depression after stroke. Cochrane Database Syst Rev. 2004;3:CD003437
  14. Fruehwald S, Gatterbauer E, Rehak P, et al. Early fluoxetine treatment of post-stroke depression–a three-month double-blind placebo-controlled study with an open-label long-term follow up. J Neurol. 2003;250:347–351
  15. Williams LS, Kroenke K, Bakas T, et al. Care management of poststroke depression: A randomized, controlled trial. Stroke. 2007;38:998–1003
  16. Watkins CL, Auton MF, Deans CF, et al. Motivational interviewing early after acute stroke: A randomized, controlled trial. Stroke. 2007;38:1004–1009
  17. Arias B, Catalan R, Gasto C, et al. 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study. J Clin Psychopharmacol. 2003;23:563–567
  18. Durham LK, Webb SM, Milos PM, et al. The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder. Psychopharmacology (Berl). 2004;174:525–529
  19. Teri L. Behavioral treatment of depression in patients with dementia. Alzheimer Dis Assoc Disord. 1994;8(suppl):66–74
  20. Logsdon RG, Teri L. Depression in Alzheimer's disease patients: Caregivers as surrogate reporters. J Am Geriatr Soc. 1995;43:150–155
  21. Teri L, Logsdon RG, McCurry SM. The Seattle protocols: Advances in behavioral treatment of Alzheimer's disease. In:  Grundman M,  Feldman H,  Fitten LJ, et al. editor. Research and practice in Alzheimer's disease. Paris: Serdi Publisher; 2005;p. 153–158
  22. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res. 1982;17:37–49
  23. Freedland KE, Skala JA, Carney RM, et al. The Depression Interview and Structured Hamilton (DISH): Rationale, development, characteristics, and clinical validity. Psychosom Med. 2002;64:897–905
  24. Teri L, Logsdon RG. Methodologic issues regarding outcome measures for clinical drug trials of psychiatric complications in dementia. J Geriatr Psychiatry Neurol. 1995;8(suppl):S8–S17
  25. Teri L, Logsdon RG, Uomoto J, et al. Behavioral treatment of depression in dementia patients: A controlled clinical trial. J Gerontol B Psychol Sci Soc Sci. 1997;52:159–166
  26. Teri L, Logsdon RG, McCurry SM. Nonpharmacologic treatment of behavioral disturbance in dementia. Med Clin North Am. 2002;86:641–656viii
  27. Logsdon RG, Teri L. The Pleasant Events Schedule-AD: Psychometric properties and relationship to depression and cognition in Alzheimer's disease patients. Gerontologist. 1997;37:40–45
  28. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62
  29. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278–296
  30. Duncan PW, Wallace D, Lai SM, et al. The stroke impact scale version 2.0: Evaluation of reliability, validity and sensitivity to change. Stroke. 1999;30:2131–2140
  31. Collin C, Wade DT, Davies S, et al. The Barthel ADL Index: A reliability study. Int Disabil Stud. 1988;10:61–63
  32. Mahoney FI, Barthel DW. Functional evaluation: The Barthel index. Md State Med J. 1965;14:61–65
  33. Scholte OP, Reimer WJ, de Haan RJ, et al. Assessment of burden in partners of stroke patients with the sense of competence questionnaire. Stroke. 1998;29:373–379
  34. Mynors-Wallis LM, Gath DH, Lloyd-Thomas AR, et al. Randomized controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. BMJ. 1995;310:441–445
  35. Mynors-Wallis L. Problem-solving treatment: Evidence for effectiveness and feasibility in primary care. Int J Psychiatry Med. 1996;26:249–262
  36. Mynors-Wallis L, Davies I, Gray A, et al. A randomized controlled trial and cost analysis of problem-solving treatment for emotional disorders given by community nurses in primary care. Br J Psychiatry. 1997;170:113–119
  37. Catalan J, Gath DH, Anastasiades P, et al. Evaluation of a brief psychological treatment for emotional disorders in primary care. Psychol Med. 1991;21:1013–1018
  38. Keller MB, McCullough JP, Klein DN, et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med. 2000;342:1462–1470
  39. Murphy GE, Simons AD, Wetzel RD, et al. Cognitive therapy and pharmacotherapy: Singly and together in the treatment of depression. Arch Gen Psychiatry. 1984;41:33–41
  40. Murphy GE, Carney RM, Knesevich MA, et al. Cognitive behavior therapy, relaxation training, and tricyclic antidepressant medication in the treatment of depression. Psychol Rep. 1995;77:403–420
  41. Reynolds CF, Frank E, Perel JM, et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: A randomized controlled trial in patients older than 59 years. JAMA. 1999;281:39–45
  42. Banerjee S, Shamash K, Macdonald AJ, et al. Randomized controlled trial of effect of intervention by psychogeriatric team on depression in frail elderly people at home. BMJ. 1996;313:1058–1061
  43. Mossey JM, Knott KA, Higgins M, et al. Effectiveness of a psychosocial intervention, interpersonal counseling, for subdysthymic depression in medically ill elderly. J Gerontol A Biol Sci Med Sci. 1996;51:M172–M178

 Supported by the National Institute of Nursing Research, National Institutes of Health grant No. R01NR007755 and registered with the clinical trials identifier: NCT00194454 http://www.clinicaltrials.gov/ct/show/NCT00194454?order=1.

PII: S1052-3057(07)00206-6

doi: 10.1016/j.jstrokecerebrovasdis.2007.12.002

Journal of Stroke & Cerebrovascular Diseases
Volume 17, Issue 3 , Pages 109-115 , May 2008

Article Tools